Meeting convened to address financing the elimination of viral hepatitis in Mongolia

12 May 2016 Bridie Taylor

At the World Health Assembly later this month, 194  Member States are expected to adopt World Health Organization’s first ever Elimination Strategy for Viral Hepatitis, which outlines a goal of eliminating hepatitis by 2030. Implementing the strategy will save 7.1 million lives, reduce mortality by 65% and increase treatment to 80% by 2030, but it will also cost billions of dollars to implement it globally.

On 4 – 5 May, together with the Mongolian Ministry of Health and Sports and the World Health Organisation Mongolia, the World Hepatitis Alliance convened the Mongolian Innovative Financing Dialogue on Viral Hepatitis in Ulaanbaatar, Mongolia to discuss innovative financing options for viral hepatitis in Mongolia.

Viral hepatitis is the second biggest killer in Mongolia, affecting up to 22% of Mongolians. In November 2015 the Mongolian Government committed to a strategy to eliminate hepatitis C in the country by 2030.

The meeting was the first of its kind and was called to review the current financing mechanisms of hepatitis care and treatment in Mongolia and discuss innovative financing options and their viability in Mongolia.

Bringing together key state holders from relevant Mongolian ministries, the Mongolian National Centre for Communicable Diseases, WHO Mongolia, WHO WPRO, Asian Development Bank, World Bank, pharmaceuticals and NGOs, presentations gave an overview of the current situation and innovative financing options, such as tax, loans and public-private partnerships. Throughout the discussions the issue of reducing the cost of treatment came to the fore.

A report with a summary of the meeting will be available soon.